DK0796103T3 - Anvendelse af røgelse til behandling af Alzheimer-sygdommen - Google Patents

Anvendelse af røgelse til behandling af Alzheimer-sygdommen

Info

Publication number
DK0796103T3
DK0796103T3 DK95940992T DK95940992T DK0796103T3 DK 0796103 T3 DK0796103 T3 DK 0796103T3 DK 95940992 T DK95940992 T DK 95940992T DK 95940992 T DK95940992 T DK 95940992T DK 0796103 T3 DK0796103 T3 DK 0796103T3
Authority
DK
Denmark
Prior art keywords
incense
disease
treat alzheimer
derivative
physiologically acceptable
Prior art date
Application number
DK95940992T
Other languages
Danish (da)
English (en)
Inventor
Rainer Etzel
Original Assignee
Ayurmedica Arzneimittelforschu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayurmedica Arzneimittelforschu filed Critical Ayurmedica Arzneimittelforschu
Application granted granted Critical
Publication of DK0796103T3 publication Critical patent/DK0796103T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95940992T 1994-12-13 1995-11-21 Anvendelse af røgelse til behandling af Alzheimer-sygdommen DK0796103T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4444288A DE4444288A1 (de) 1994-12-13 1994-12-13 Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
PCT/EP1995/004586 WO1996018407A1 (de) 1994-12-13 1995-11-21 Verwendung von weihrauch zur behandlung der alzheimer-krankheit

Publications (1)

Publication Number Publication Date
DK0796103T3 true DK0796103T3 (da) 2001-03-05

Family

ID=6535638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940992T DK0796103T3 (da) 1994-12-13 1995-11-21 Anvendelse af røgelse til behandling af Alzheimer-sygdommen

Country Status (15)

Country Link
US (1) US5720975A (cs)
EP (1) EP0796103B1 (cs)
JP (1) JPH10510276A (cs)
CN (1) CN1092973C (cs)
AT (1) ATE198550T1 (cs)
CA (1) CA2207437A1 (cs)
CZ (1) CZ288071B6 (cs)
DE (2) DE4444288A1 (cs)
DK (1) DK0796103T3 (cs)
ES (1) ES2153906T3 (cs)
GR (1) GR3035402T3 (cs)
PL (1) PL320687A1 (cs)
PT (1) PT796103E (cs)
RU (1) RU2184562C2 (cs)
WO (1) WO1996018407A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531067A1 (de) * 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
WO2002024173A2 (de) * 2000-09-20 2002-03-28 R.P. Scherer Gmbh & Co. Kg Orale zubereitungsformen von extrakten aus boswellia
WO2002066491A1 (en) * 2001-02-15 2002-08-29 Sabinsa Corporation Water soluble boswellic acids, their preparation and use for treating imflammatory conditions
GB0201508D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Organic compounds
CN1304007C (zh) * 2002-02-04 2007-03-14 中国医学科学院药物研究所 乙酰乳香酸在制备肿瘤转移抑制剂中的应用
WO2004082699A2 (de) * 2003-03-18 2004-09-30 Keyneurotek Ag Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischämie und/oder schädel/hirntrauma
DE10331750A1 (de) * 2003-07-14 2005-02-10 Keyneurotek Ag Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit
CN100569245C (zh) * 2005-06-02 2009-12-16 成都中医药大学 乳香在制备治疗痛风的药物中的用途
KR101682512B1 (ko) 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
WO2010105821A1 (de) 2009-03-17 2010-09-23 Herta Ertelt Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung
US10940175B2 (en) 2009-07-18 2021-03-09 Compton Developments Ltd. Inhibitor of inflammatory conditions
EP3868391B1 (en) * 2009-07-18 2024-05-22 Compton Developments Limited Therapeutic uses of an organic solvent extract of boswellia frereana oleoresin
US12005094B2 (en) 2009-07-18 2024-06-11 Compton Developments Ltd. Inhibitor of inflammatory conditions
US8828377B2 (en) 2010-03-15 2014-09-09 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
CA2793045A1 (en) * 2010-03-15 2011-09-22 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
WO2012032523A2 (en) * 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
ITPD20120343A1 (it) * 2012-11-13 2014-05-14 Matteo Bevilacqua Composto in particolare per la cura della depressione e dell'ansia
CN103393740B (zh) * 2013-07-31 2015-10-14 中国人民解放军第四军医大学 乳香提取物在防治心脑血管或肝肾损伤中应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064823A (en) * 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
CA1330944C (en) * 1988-08-24 1994-07-26 De-Hua Li Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
CN1053363A (zh) * 1990-09-11 1991-07-31 李竞 能预防和缓解痛经的香水
US5280119A (en) * 1991-11-01 1994-01-18 Boron Biologicals, Inc. Heterocyclic amine-boranes, and method of inhibiting DNA topoisomerase activity and/or combatting inflammation, hyperlipidemia, and/or neoplasia using amine-borane compounds
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
CN1033331C (zh) * 1992-11-13 1996-11-20 中国科学院长春应用化学研究所 聚芳醚砜/液晶高聚物分子复合材料及制备方法
CN1046088C (zh) * 1992-12-19 1999-11-03 管遵信 一种中药美容液及其生产方法
CN1030373C (zh) * 1993-03-27 1995-11-29 张会来 腰痹灵
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor

Also Published As

Publication number Publication date
ATE198550T1 (de) 2001-01-15
US5720975A (en) 1998-02-24
GR3035402T3 (en) 2001-05-31
CZ288071B6 (cs) 2001-04-11
CA2207437A1 (en) 1996-06-20
CN1173134A (zh) 1998-02-11
JPH10510276A (ja) 1998-10-06
RU2184562C2 (ru) 2002-07-10
DE59508961D1 (de) 2001-02-15
ES2153906T3 (es) 2001-03-16
CN1092973C (zh) 2002-10-23
DE4444288A1 (de) 1996-06-20
PT796103E (pt) 2001-04-30
EP0796103A1 (de) 1997-09-24
WO1996018407A1 (de) 1996-06-20
PL320687A1 (en) 1997-10-27
CZ177397A3 (en) 1997-11-12
EP0796103B1 (de) 2001-01-10

Similar Documents

Publication Publication Date Title
DK0796103T3 (da) Anvendelse af røgelse til behandling af Alzheimer-sygdommen
BR0008323A (pt) Derivado de gabapentina para a prevenção e o tratamento de dor visceral
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
DK0854709T4 (da) Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
DE69327328D1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
ES2145902T3 (es) Aplicacion del riluzole en el tratamiento de las enfermedades mitocondriales.
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE78168T1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
WO2004082699A3 (de) Verwendung von weihrauch oder seinen hydrierungsprodukten zur prophylaxe und/oder behandlung von zerebraler ischämie und/oder schädel/hirntrauma
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
EP0880967A3 (de) Nephroprotektive Arzneimittel